VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,858,937 | -34.4% | 1,587,717 | 0.0% | 0.02% | -41.7% |
| Q2 2023 | $10,463,055 | -2.9% | 1,587,717 | 0.0% | 0.04% | -5.3% |
| Q1 2023 | $10,780,598 | +91782.7% | 1,587,717 | 0.0% | 0.04% | -9.5% |
| Q4 2022 | $11,733 | -99.9% | 1,587,717 | -0.1% | 0.04% | -30.0% |
| Q3 2022 | $15,708,000 | -43.0% | 1,589,860 | -37.1% | 0.06% | -41.2% |
| Q2 2022 | $27,539,000 | +83.0% | 2,526,480 | +89.9% | 0.10% | +142.9% |
| Q1 2022 | $15,050,000 | +112.1% | 1,330,712 | +194.3% | 0.04% | +100.0% |
| Q4 2021 | $7,095,000 | +374.9% | 452,220 | +418.9% | 0.02% | +320.0% |
| Q3 2021 | $1,494,000 | -3.4% | 87,145 | +21.2% | 0.01% | 0.0% |
| Q2 2021 | $1,546,000 | -73.4% | 71,875 | -81.5% | 0.01% | -79.2% |
| Q1 2021 | $5,822,000 | -11.6% | 387,605 | -22.7% | 0.02% | -17.2% |
| Q4 2020 | $6,585,000 | +47.8% | 501,168 | +8.7% | 0.03% | +16.0% |
| Q3 2020 | $4,455,000 | -16.7% | 461,184 | -1.4% | 0.02% | -26.5% |
| Q2 2020 | $5,351,000 | – | 467,728 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |